Alphabet Inc. - Q1 2020 holdings

$1.52 Billion is the total value of Alphabet Inc.'s 28 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 20.8% .

 Value Shares↓ Weighting
JD  JD com Incspon adr cl a$548,916,000
+15.0%
13,553,4740.0%36.01%
+24.7%
LYFT  Lyft Inc$344,458,000
-37.6%
12,828,9640.0%22.60%
-32.3%
DXCM  Dexcom Inc$216,946,000
+23.1%
805,6810.0%14.23%
+33.6%
ONEM New1Life Healthcare Inc$112,224,0006,183,154
+100.0%
7.36%
RCUS  Arcus Biosciences Inc$70,091,000
+37.4%
5,049,7860.0%4.60%
+49.1%
VIR  Vir Biotechnology Inc$57,117,000
+172.5%
1,666,6660.0%3.75%
+195.7%
WORK  Slack Technologies Inc.$34,886,000
+19.4%
1,299,7710.0%2.29%
+29.5%
MGTA  Magenta Therapeutics Inc$20,970,000
-58.6%
3,339,1380.0%1.38%
-55.0%
SDGR NewSchrodinger Inc$19,349,000448,722
+100.0%
1.27%
RAPT  RAPT Therapeutics Inc$17,783,000
-23.0%
836,0590.0%1.17%
-16.4%
BEAM NewBeam Therapeutics Inc$11,946,000663,691
+100.0%
0.78%
CRWD  Crowdstrike Hldgs Inccl a$9,522,000
+11.6%
171,0200.0%0.62%
+21.1%
SPRO  Spero Therapeutics Inc$8,989,000
-16.0%
1,112,4730.0%0.59%
-8.8%
FULC BuyFulcrum Therapeutics Inc$8,670,000
-27.1%
726,189
+1.7%
0.57%
-20.9%
CRTX  Cortexyme Inc$8,626,000
-18.8%
189,1220.0%0.57%
-11.8%
SNAP  Snap Inccl a$6,227,000
-27.2%
523,7100.0%0.41%
-20.9%
GRTS  Gritstone Oncology Inc$5,407,000
-35.1%
929,0220.0%0.36%
-29.6%
ALEC  Alector Inc$4,244,000
+40.1%
175,8660.0%0.28%
+51.9%
AUTL  Autolus Therapeutics PLCspon ads$4,189,000
-54.6%
699,3520.0%0.28%
-50.7%
EVLO  Evelo Biosciences Inc$3,982,000
-7.5%
1,060,4950.0%0.26%
+0.4%
CLDR  Cloudera Inc$3,366,000
-32.3%
427,7100.0%0.22%
-26.6%
IDYA  Ideaya Biosciences Inc$3,103,000
-45.1%
753,1870.0%0.20%
-40.4%
MWK  Mohawk Group Hldgs Inc$1,785,000
-71.3%
1,055,9540.0%0.12%
-68.9%
UBER SellUber Technologies Inc$1,161,000
-99.0%
41,585
-98.9%
0.08%
-98.9%
DBX  Dropbox Inccl a$236,000
+1.3%
13,0330.0%0.02%
+7.1%
NET ExitCloudflare Inc$0-1,632,519
-100.0%
-1.68%
FTSV ExitForty Seven Inc$0-1,030,644
-100.0%
-2.45%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPERO THERAPEUTICS INC24Q3 20233.5%
AUTOLUS THERAPEUTICS PLC22Q3 20232.8%
Magenta Therapeutics Inc.21Q2 20233.8%
DEXCOM INC20Q3 202317.4%
Evelo Biosciences Inc.20Q1 20231.6%
ALECTOR INC19Q3 20231.1%
Lyft Inc18Q2 202351.9%
QUINCE THERAPEUTICS INC18Q3 20230.6%
Arcus Biosciences Inc17Q1 202212.7%
FULCRUM THERAPEUTICS INC17Q3 20230.7%

View Alphabet Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Alphabet Inc. Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ARRIS International plcFebruary 14, 20197,603,5004.4%

View Alphabet Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
8-K2024-04-25
1442024-04-17
1442024-04-17
42024-04-17
42024-04-15
1442024-04-12
42024-04-04
1442024-04-03
1442024-04-03
42024-04-02

View Alphabet Inc.'s complete filings history.

Compare quarters

Export Alphabet Inc.'s holdings